MABLOGIX

USPTO USPTO 2011 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke MABLOGIX wurde als Wortmarke am 29.11.2011 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails

Markenform Wortmarke
Aktenzeichen 85482863
Anmeldedatum 29. November 2011
Veröffentlichungsdatum 11. September 2012

Markeninhaber

1872 Pratt Drive, Suite 1400
24060 Blacksburg
US

Markenvertreter

Waren und Dienstleistungen

1 Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting cellular activity or gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in modifying and regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; antibodies for scientific and research use; antibodies for regulating, modifying or regulating cellular functions in plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting cellular activity or gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications
5 Chemical preparations for medical and veterinary purposes, namely, chemical preparations for regulating, modifying, or restricting cellular activity or gene expression for purposes of treating diseases and genetic disorders; chemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for antibody therapy analysis; Pharmaceutical preparations for modifying or regulating one or more cellular functions of mammals, fungi, plants, and bacteria and transgenic mammals, fungi, plants, and bacteria ; transgenic plants, fungi and bacteria for medical and veterinary purposes; antibodies for use in disease testing
45 Technology transfer services, namely, licensing and transfer of intellectual property
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1385482863